Intrinsic Value of S&P & Nasdaq Contact Us

Sharps Technology, Inc. STSS NASDAQ

NASDAQ Capital Marke • Healthcare • Medical - Instruments & Supplies • US • USD

SharesGrow Score
38/100
1/6 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow

Sharps Technology, Inc. (STSS) — Analyst outlook / Analyst consensus target is. Based on 1 analyst ratings, the consensus is bullish — 1 Buy.

Analysts estimate Earnings Per Share (EPS) of $-990.00 and revenue of $0.05B for the next fiscal year.

Earnings Per Share (EPS) track record: 2024: actual $-2,220.05 vs est $-990.00 (missed -124.2%). 2025: actual $-11.16 vs est $-1.10 (missed -914.5%). Analyst accuracy: 27%.

STSS Analyst Ratings

Buy
1
Ratings
1 Buy
Based on 1 analysts giving stock ratings to Sharps Technology, Inc. in the past 3 months
Rating breakdown
Buy
1 100%
100%
Buy
1 analysts
0%
Hold
0 analysts
0%
Sell
0 analysts

EPS Estimates — STSS

27%
Analyst Accuracy
Inaccurate
2 years compared
Actual vs Estimate
2024 Actual –$2,220.05 vs Est –$990.00 ▼ 55.4% off
2025 Actual –$11.16 vs Est –$1.10 ▼ 90.1% off
Profitability Outlook
Company has been making losses in all recent fiscal years. EPS is improving but still negative. Analysts expect losses to continue near-term.

Revenue Estimates — STSS

0%
Analyst Accuracy
Inaccurate
1 year compared
Actual vs Estimate
2025 Actual $0.000B vs Est $0.002B ▼ 683.9% off
Revenue Trend
Revenue has been relatively flat. Analysts expect stable revenue going forward.
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message